Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post Traumatic Acute Pain in the Emergency Department

NCT05229055 is registered in ClinicalTrials.gov with University of Monastir as lead sponsor.

NCT NCT05229055
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05229055 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Ketamine Versus Subcutaneous Ketamine for Treatment of Post Traumatic Acute Pain in the Emergency Department
Lead sponsor
University of Monastir
Phase
Phase 2/3
Overall status
Completed
Start date
April 15, 2023
Completion date
December 31, 2025
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain